Member Info for spardun

Anyone else around? Bought in just before the name change with a modest holding as a geographic diversifier. Interesting RNS today showing the potential of Meize Energy. But so little interest, with only 6 transactions in this new (UK) financial year and two of those might have been a bed-and-ISA. Despite a recent appearance on one of the webcasts, a bit more publicity is needed to stimulate awareness and appeal to a wider audience.

Yet another modest top up (the 27k was not mine sadly), so gradually accumulating a satisfying holding from my initial purchase at 17p. Had to pay full ask but hopefully that will be immaterial. Looks like plenty of mileage ahead from the helpful information posted. Plenty of patience as well so am very much a LTH. Keep motoring ENET!

Interesting discussions, but I sense different timescales for "patience" between the various contributors to this excellent board. We all know the saying of the stock market being a mechanism to transfer wealth from the impatient to the patient. This board generally seems to have a patient and engaged crew, unlike several others. We have all, presumably, done our due diligence before investing, and we have a very good information flow to help form and review our judgements. We all have our own timescales. ENET seems a classic example of "Rome wasn't built in a week". So, yes, prices drift on no news, and move up on good news and good trading updates, then drift again on a "rinse and repeat" cycle. We now have a good understanding of the way ENET do business and hence why there is not a plethora of RNS announcements. With another share in the portfolio, there was a series of small, incremental RNSs which had the an adverse short term effect on the share price as everyone was frustrated that each RNS was "not the big one". So I patiently look forward to the next trading update, with any "big news" as a bonus. UK investors will be familiar with the quote from Corporal Jones: "Don't panic Captain Mainwaring!".
AIMHO. GLALTH

It wouldn't surprise me if my namesake Gerard pulled out a St Patrick's Day special: it would be quite appropriate! Now where are those four leaf clovers?

Welcome on "Board" Martyn. Interesting that Interactive Investor is showing your trade as "unknown". Hopefully it will do well for you.

Another modest addition to my gradually increasing total, this time 5k at 33.34p. The bid at the time was 31.8p, and the spread was shown as 31 - 34p. Used Interactive Investor as usual. My next chunk will be part of next year's ISA, but am wary of a potential spike on 6 April with demand from UK investors.
GLALTH.

Indeed Skid: let's hope from the dual perspectives of rugby and ENET that 2021 will be the year of the Dragon! However, with the way ENET seems to be going about its business, I sense the share price might be getting larger hikes via half yearly trading updates than "regular monthly updates". Thanks to the more knowledgeable contributors we can see the direction of travel, and, as a patient Board of seemingly LTHs only, IMHO we don't need the blockbuster headlines which attracts the traders and rampers. Daily volume is significantly higher than 6 months ago. But one day, a trading update could well produce such a blockbuster headline once ENET hits critical mass, and then momentum often takes over.
With a diversified portfolio to spread the risk, I'm now just focussing on increasing my allocations in ENET and ORPH as with a fair wind, both appear to have clear potential for both significant long term capital gains and dividends (cash or in specie). So for UK investors, the double if not triple tax advantages of ISAs/AIM shares require thoughtful consideration of which shares to shelter in the ISA.
However I am aware of the very international nature of this Board, so apologies for the domestic focus of this post. And for the Sinophiles, 2021 is actually the Year of the Ox!
Good luck all LTH.

Masca
FWIW I also use Interactive Investors and am UK based. Even so, they don't give much away. My two most recent buys were at 32.94p, when the spread was 32p > 33p, and at 37.699p when the spread was 36.65 > 37.7p. I don't subscribe to Level 2 (should I be, if I make 2 or 3 transactions, almost all buys, per month?).
My first buy of ENET was last August @ 15.6p. At that time there were, on a good day, about 4 trades on average. ENET has come a long way since then with steady rather than spectacular progress. And as a LTH, I'm modestly accumulating. However, a good slice of next year's ISA allocation will be heading in this direction. Onwards and upwards, but not too fast until after 6 April!
Finally it is a pleasure to be on such a civilised Board so thanks again to the regular posters, particularly TL, for the quality information researched and shared.

Bazzaman
Thanks also from me for posting the weblink.
I am in a comfort zone of having bought @ 5.8p and topped up @ 11.65p. However CF's presentation showing the flight path of the company suggested to me that there is so much more to go for, so I've added a modest addition @ 28.99p.
When the time comes for the announcement of the first non-core activity to float, it is interesting to consIder whether the record date for an in specie entitlement will closing time the night before the RNS, or subsequently, dependent perhaps on the approval process required to endorse the proposal. A potential FOMO was another encouragement to further invest today.

This led me to also consider the material value of one's potential in specie holdings in each floated company. If shareholders are considering selling their new shares, the larger their holding in the new companies, the smaller the percentage hit from trading costs. There might of course be an option for existing shareholders in ORPH to further invest through each IPO. So for the moment, ORPH looks the preferred home for any further free cash.
One last thought: with the ongoing hint of a NASDAQ listing for at least one of the floated companies, I need to check whether ADRs are eligible for admission to an ISA/JISA/SIPP. Now if any of you learned ladies and gentlemen already know the answer, that would be a great help.
"Looking good Houston/Cathal".
Spardun

I suspect most of this is already factored in. It always pays to read and re-read RNSs, as below, issued following a leak in the Financial Times, if I recall correctly:

24 September 2020

Open Orphan plc

("Open Orphan" or the "Company")

Statement re price movement and press speculation

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials notes the recent share price movement and press speculation regarding UK government-funded Coronavirus human challenge studies.

The Company confirms that it is in advanced negotiation with the UK Government and other partners for a Coronavirus challenge study in the UK. While negotiations continue, it is expected that in the event that a contract is agreed revenue will be in excess of £7 million, being the approximate anticipated revenue for a Coronavirus challenge study as indicated by the Company on 22 May 2020. However, there can be no certainty that these discussions will lead to a new contract until final negotiations are concluded. The Company will update the market in due course as appropriate. .....................

Nevertheless, official confirmation could give a little extra boost, and with it, excellent publicity, with ORPH helping progress to conquer this wretched virus. And, yes, IMHO, it would require a confirming RNS.

Thanks for clarifying Grace. The clever subtlety of your messages, now seen in context, is now fully understood and endorsed.

Good luck with our investments here in GDR. Interesting times with AIM shares at present. Plenty of potential big winners out there. I like to diversify with long term modest investments in a range of small companies rather than go for "one big bang or nothing" approach. It spreads the risk etc. They do say that diversification is the only free lunch in investing. Biotech, green economy, 5G etc, there's plenty to go for as the world's economy transitions. My main fear is that those small companies who do make technological and economic breakthroughs get taken over far far too cheaply by the big boys thanks to the usual shenanigans that go on, almost always at the expense of the PIs.

Cheers.

11.02

Grace83
Are you proud of this post?

JayHayes
ALL Welsh speakers are at least bilingual. Greetings by public officials are usually bilingual, such as "Bore Da, Good Morning", and are warm and courteous. You would not have been spoken to in Welsh only in north east Wales. Respect please.

Indeed, and my modest top up at 09.23.38 at 17.4p, was a buy but shown as a sell, and then mysteriously disappeared! No doubt it will return.
Very pleased but surprised to have got in again at such a level considering the importance of the RNS.
But this does give me the opportunity to thank our key posters for their valuable and knowledgeable contributions to this board, nothwithstanding our individual responsibilities to do our own research.

My modest transaction at 8.1p at 08:54:16 was a buy, not a sell as currently shown.

My modest transaction of 50,000 at 1.979p at 12.22.44 was a buy, not, as suggested, a sell. I suspect that the same applies to a number of those transactions around that time.

Re the minimum two years holding for IHT exemption, I recall reading a few years ago that there was no definitive HMRC list of which AIM shares do/do not qualify for this exemption. Apparently if a company is also quoted on an additional exchange as well as AIM, it does not qualify. I also read that some asset managers/ advisers can package a portfolio of AIM shares that they believe DO qualify. However this is specialist stuff above my pay grade so: no advice given/DYOR.

My modest trade for 2,500 shares at 14.17.28 at 53p was a buy, not a sell, as I suspect were the immediately prior trades at the same price.

My modest trade at 16.22 was a buy, not a sell as shown.
Spardun